6-thioguanine selectively kills BRCA2-defective tumors and overcomes PARP inhibitor resistance. (Cancer research, 2010)

(untitled) - Issaeva, N; Thomas, H; Djureinovic, T; Djurenovic, T; Jaspers, J; Stoimenov, I; Kyle, S; Pedley, N; Gottipati, P; Zur, R; Sleeth, K; Chatzakos, V; et al.